Kidney Disease Research
Diverse Collection Tailored for Excellence
Central BioHub is paving the way for kidney disease research by offering unrivaled access to superior human biospecimens. Our online marketplace aims to provide scientists and researchers with the resources they need to examine, innovate, and discover. We understand the complexity and diversity of kidney diseases, which is why we have categorized our biospecimens collection into three main subcategories: Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), and Kidney Cancer.
Sample Specifications
The sample specifications for Central BioHub's biospecimen collection include samples relevant to Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), and Kidney Cancer, carefully cataloged with ICD-10 codes N17+ for AKI and N18+ for CKD.
The available matrices for these specimens are Plasma, Serum, and Urine, providing a versatile foundation for a wide array of research applications. These specifications ensure that researchers have access to a diverse range of high-quality samples, facilitating studies aimed at understanding the progression, mechanisms, and potential treatments for both acute and chronic kidney diseases, as well as Kidney Cancer.
Acute Kidney Injury (AKI)
Acute Kidney Injury (AKI) is a critical condition characterized by the sudden onset of kidney failure or damage within a short period. This condition, classified under ICD-10 code N17, requires immediate medical attention to prevent long-term damage. Research into AKI focuses on understanding its pathophysiology, identifying early biomarkers, and developing effective treatments.
Importance of AKI Research
-
Early Detection: Identifying reliable biomarkers for early AKI detection can significantly improve patient outcomes.
-
Therapeutic Development: Researching anti-inflammatory agents and regenerative medicine approaches to treat AKI.
-
Prevention Strategies: Developing strategies to prevent AKI in high-risk populations, such as those undergoing major surgeries or suffering from severe infections.
Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD) is a progressive condition that leads to the gradual loss of kidney function over time. It is a significant global health issue, often resulting from conditions like diabetes, hypertension, and IgA nephropathy. CKD is categorized into five stages, from mild kidney damage in Stage I to complete kidney failure in Stage V, necessitating comprehensive research to develop effective management and treatment strategies.
Key Areas of CKD Research
-
Pathophysiology: Investigating the molecular and cellular mechanisms that cause kidney damage and fibrosis.
-
Biomarkers: Identifying biomarkers for early CKD detection and monitoring disease progression.
-
Therapeutics: Developing new drugs to slow or halt CKD progression, including anti-fibrotic and anti-inflammatory agents.
-
Dialysis and Transplantation: Enhancing dialysis techniques and improving kidney transplantation outcomes to provide better care for CKD patients.
Kidney Cancer
Kidney Cancer, particularly renal cell carcinoma, is a significant area of research due to its rising incidence and potential lethality. Understanding the genetic and molecular basis of kidney cancer is crucial for developing targeted therapies and improving diagnostic tools. Our biospecimens support studies into various aspects of kidney cancer, from genetic mutations to the efficacy of new treatments.
Focus Areas in Kidney Cancer Research
-
Genetic Research: Studying mutations that drive kidney cancer and developing targeted therapies.
-
Immunotherapy: Exploring the potential of immunotherapy to treat kidney cancer by harnessing the body's immune system.
-
Early Detection: Developing non-invasive diagnostic tools, such as blood and urine tests, for early detection of kidney cancer.
Why Choose Central BioHub for Your Research Needs?
Central BioHub offers an extensive and diverse collection of biospecimens, including those from kidney diseases, acute and chronic conditions, and renal cancer. Our comprehensive repository allows for a wide range of study designs and objectives, facilitating groundbreaking research in nephrology and oncology.
1. Quality and Specificity: Our biospecimens are sourced from well-characterized patient cohorts, ensuring high-quality samples that provide valuable insights into kidney diseases. Each sample is selected for its clinical relevance, supporting robust and impactful research.
2. Advanced Search Options: Central BioHub provides advanced search options for procuring kidney disease samples. Researchers can apply filters and select samples, making it easy to find the necessary samples for their studies.
3. Comprehensive Support: We are committed to supporting the scientific community by providing access to high-quality biospecimens and comprehensive customer support. Our team of experts is available to assist researchers in selecting the right samples and addressing any questions or concerns they may have.
4. Collaboration and Innovation: By partnering with Central BioHub, researchers can leverage our extensive collection of biospecimens to advance their studies and make groundbreaking discoveries. Together, we can contribute to the development of new treatments and management strategies for kidney diseases, improving the lives of millions of patients worldwide.
Explore Our Kidney Disease Biospecimen Collection
Explore our extensive collection of kidney disease biospecimens today and take a pivotal step toward unlocking new discoveries in kidney disease treatment and management. Our commitment to quality, diversity, and support for the scientific community makes Central BioHub the ideal source for your research needs. Together, we can make a significant impact on the lives of those affected by kidney diseases.
Find Kidney Disease Samples for Research in our New Inventory:
Register now for free and find the research specimen that best fits your needs by clicking on Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.
Central BioHub - Order biospecimens online.